Publications by authors named "Steve Jeremiah"

Claim this Profile
M
Metronomic administration of ibandronate and its anti-angiogenic effects in vitro.
Claire Morgan, Steve Jeremiah, John Wagstaff

Microvasc Res· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibandronate reduces endogenous reactive oxygen species levels in cultured prostate cancer and endothelial cells.
Claire Morgan, Steve Jeremiah, John Wagstaff

Microvasc Res· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas.
Jorge Lima, Vítor Trovisco, Paula Soares, Valdemar Máximo, João Magalhães, Steve Jeremiah

Cancer Lett· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of BRAF T1796A mutation in papillary thyroid carcinoma relates to age of patient at diagnosis and not to radiation exposure.
Ned Powell, Steve Jeremiah, Mariko Morishita, Ed Dudley, Jackie Bethel

J Pathol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas.
Jorge Lima, Vítor Trovisco, Paula Soares, Valdemar Máximo, João Magalhães, Steve Jeremiah

J Clin Endocrinol Metab· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromosomal anomalies on 6p25 in iris hypoplasia and Axenfeld-Rieger syndrome patients defined on a purpose-built genomic microarray.
Rosemary Ekong, Steve Jeremiah, David Judah, Ordan Lehmann, Farideh Mirzayans

Hum Mutat· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis